Mayinglong Pharmaceutical Group Co., Ltd.

XSSC:600993 Stock Report

Market Cap: CN¥10.8b

Mayinglong Pharmaceutical Group Future Growth

Future criteria checks 2/6

Mayinglong Pharmaceutical Group is forecast to grow earnings and revenue by 18.9% and 14.4% per annum respectively. EPS is expected to grow by 18.8% per annum. Return on equity is forecast to be 14.7% in 3 years.

Key information

18.9%

Earnings growth rate

18.8%

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth rate14.4%
Future return on equity14.7%
Analyst coverage

Low

Last updated19 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:600993 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,8407676727482
12/31/20254,2766875016282
12/31/20243,7275733814372
9/30/20243,482482543845N/A
6/30/20243,424474602864N/A
3/31/20243,259453497754N/A
12/31/20233,137443356604N/A
9/30/20233,19448118162N/A
6/30/20233,245488270396N/A
3/31/20233,416529286388N/A
12/31/20223,532479267342N/A
9/30/20223,640513600665N/A
6/30/20223,644482547607N/A
3/31/20223,473485522580N/A
12/31/20213,385465532597N/A
9/30/20213,58745781144N/A
6/30/20213,479439-1355N/A
3/31/20213,31742792158N/A
12/31/20202,792419238283N/A
9/30/20202,518396651687N/A
6/30/20202,411378543582N/A
3/31/20202,431336425468N/A
12/31/20192,705360445492N/A
9/30/20192,528349190233N/A
6/30/20192,400290344374N/A
3/31/20192,311241355385N/A
12/31/20182,198176283308N/A
9/30/20182,152205289321N/A
6/30/20182,041248N/A185N/A
3/31/20181,861302N/A252N/A
12/31/20171,751320N/A356N/A
9/30/20171,884279N/A314N/A
6/30/20171,937266N/A377N/A
3/31/20172,013257N/A291N/A
12/31/20162,103250N/A240N/A
9/30/20161,924245N/A271N/A
6/30/20161,893238N/A117N/A
3/31/20161,833230N/A211N/A
12/31/20151,784223N/A183N/A
9/30/20151,739207N/A142N/A
6/30/20151,657215N/A197N/A
3/31/20151,642203N/A96N/A
12/31/20141,621201N/A112N/A
9/30/20141,607205N/A119N/A
6/30/20141,623199N/A90N/A
3/31/20141,605188N/A111N/A
12/31/20131,602186N/A130N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600993's forecast earnings growth (18.9% per year) is above the savings rate (2.8%).

Earnings vs Market: 600993's earnings (18.9% per year) are forecast to grow slower than the CN market (26.2% per year).

High Growth Earnings: 600993's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600993's revenue (14.4% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 600993's revenue (14.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600993's Return on Equity is forecast to be low in 3 years time (14.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y